Elevance Health (ELV) FY26 Adj. EPS view maintained at 25.50 (exp. 26.05); announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits.

Elevance Health has maintained its FY26 adjusted EPS view slightly below expectations, which could suggest a cautious outlook from management.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

White House says Trump remains open to dialogue with Kim 'without any preconditions', via Yonhap

NYC Mayor Mamdani says had a productive meeting with US President Trump; looking forward to building more housing in NYC

Elevance Health (ELV) FY26 Adj. EPS view maintained at 25.50 (exp. 26.05); announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits.

CRUDE WRAP: WTI (J6) SETTLES USD 0.21 LOWER AT USD 65.21/BBL; BRENT (J6) SETTLES USD 0.10 LOWER AT USD 70.75/BBL

Fed's Goolsbee (2027 Voter) says rates can come down, but does not want to front-load before inflation eases. We can overheat the economy, but lets not. Wants Fed to be careful

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon.
  • Felicia Norwood, Executive Vice President and Chief Health Benefits Officer, will assume responsibility for the Company’s consolidated Health Benefits organization.
  • Peter D. Haytaian has announced that he will transition from his role as Executive Vice President and President of Carelon effective May 4, 2026, in order to devote more time to family commitments.
Context

The announced changes in leadership aimed at streamlining operations might indicate a strategic pivot towards improving execution, pivotal for investor confidence. Watch for potential market reactions as this could impact the stock’s performance relative to peers in the health care sector.

Related headlines

The whole workspace, free to try.

Try it free